Nipocalimab‐aahu (IMAAVY) for Generalized Myasthenia Gravis: Redefining Treatment With FcRn Inhibition

Medicine Advances · Published 2025-12-01 · DOI 10.1002/med4.70043

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1002/med4.70043

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Neuronal Reshaping of the Tumor Microenvironment in Tumorigenesis and Metastasis: Bench to Clinic · Medicine Advances · 2025 · Same journal
• Postoperative Chemotherapy in Stage IIA Gastric Cancer: Not Always Necessary · Medicine Advances · 2026 · Same journal
• Diacerein's Role in Alleviating Inflammation and Synovial Effusion in Knee Osteoarthritis: A Novel Therapeutic Approach · Medicine Advances · 2025 · Same journal
• Surgical Management of a High‐Grade Gastrointestinal Stromal Tumor in a Morbidly Obese Patient: A Case Study · Medicine Advances · 2025 · Same journal
• The Burden and Trends of Soft Tissue and Extraosseous Sarcomas in China: An Observational Study From 1990 to 2021 · Medicine Advances · 2025 · Same journal
• Mental Health and Corresponding Interventions for Persons With Physical Disabilities: A Scoping Review · Medicine Advances · 2026 · Same journal
• The Drug Safety Framework of Avacopan: A Pharmacovigilance Study · Medicine Advances · 2026 · Same journal
• Causal Link Between Obstructive Uropathy, Estradiol, and Risk of Breast Cancer: Insights From Observational Evidence and Genetic Association Analyses · Medicine Advances · 2026 · Same journal
• Tumor Cell Migration May Be an Inherent “Foraging” Behavior · Medicine Advances · 2026 · Same journal
• Global Burden, Rising Trends, and Future Projections of Metabolic Risks‐Related Pancreatic Cancer, With Subgroup Analysis of High Body Mass Index · Medicine Advances · 2025 · Same journal